K2 Oncology
Latest round
- Series B
Last raised
- Aug 2022
Total raised
- Undisclosed
Investors
- 5
About K2 Oncology
Founded in 2016 and based in Beijing, China, K2 Oncology is a a medical technology that focuses on the development of anti-tumor drugs. The company has an R&D center of 800 square meters, a clinical medical laboratory of 1300 square meters and a GMP-level cell culture production workshop. Zhijian Sun, founder and CEO of the company, was a senior researcher at BeiGene and the head of in vitro pharmacology of the innovative drug zanubrutinib. The company has iaCyte organoid technology platform, human cell stem cell culture technology platform PDOX technology platform and organoid culture medium kit, etc. OrganoProTM Organoid Medium Kit is suitable for organoid culture of gastric cancer, ovarian cancer and breast cancer.
Who invested in K2 Oncology
5 investors across 3 rounds
See all investors in K2 Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about K2 Oncology
Who invested in K2 Oncology?
K2 Oncology has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has K2 Oncology raised?
K2 Oncology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did K2 Oncology last raise money?
K2 Oncology's most recent round on record is a Series B, in Aug 2022.
What does K2 Oncology do?
Founded in 2016 and based in Beijing, China, K2 Oncology is a a medical technology that focuses on the development of anti-tumor drugs.
Where is K2 Oncology headquartered?
K2 Oncology is headquartered in Beijing, China.
Which VCs invest in companies like K2 Oncology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at K2 Oncology's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like K2 Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.